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Abstract
Background and purpose Stroke in young individuals
is a serious public health burden. This study aimed to
characterise the various phenotypes of ischaemic stroke
in a young urban population (≤50 years old) using the
ASCOD classification system, which assigns a score to five
stroke categories: atherosclerosis, small vessel disease
(SVD), cardioembolism, other and dissection. Within each
category, a numerical score represents the degree of
causality attributed to the stroke.
Methods This retrospective study cohort was composed
of patients from an urban tertiary care academic centre.
Cases were selected by searching Get With the Guidelines
database for adults ≤50 years old with ischaemic stroke.
The study sample included 175 ischaemic strokes in 157
patients, with 16 subjects re-infarcting. Using retrospective
chart review, each stroke was scored according to the
ASCOD classification system. Multivariable logistic
regression analyses were performed to explore each
ASCOD category’s association with causal risk factors.
Results Of possible causal mechanisms, defined as
receiving a grade 1 or 2, a cardiovascular aetiology was most
prevalent (25.7%), followed by SVD (22.3%), and closely by
atherosclerosis (21.1%). Of general phenotypes, defined as
receiving a grade 1 or 2 or 3, atherosclerosis was the most
prevalent (51.4%), followed by SVD (47.4%), cardioembolism
(42.3%) and other (35.4%). 31.6% of all strokes were of
unclear aetiology. Subjects between 45 and 50 years old
were more likely to develop a cardioembolic or SVD stroke
when compared with subjects <45 years old.
Conclusion This study took a novel approach to ASCOD
phenotyping, allowing several observations: (1) In patients
with advanced atherosclerosis receiving the score A1,
the vast majority had systemic atherosclerosis in multiple
vascular territories; (2) the cardiac score C2(6), defined as a
radiographic pattern highly suggestive of a central embolic
source, may overestimate the prevalence of true cardiac
disease; (3) incidental laboratory findings may detect some
underlying pathology, but causality to the stroke is unlikely.

Introduction
While stroke is predominantly a disease of the
elderly, in the past decade, ischaemic stroke
has disproportionately affected young adults.
There is an increasing rate of stroke in young
people under 55 years old, which is a serious
public health burden. Studies indicate that
post stroke, one-half of stroke in the young
(SITY) patients do not return to work and have

poor functional recovery.1 SITY patients have a
longer time period for potential reinfarction;
consequently, secondary prevention is crucial.
However, it is unclear whether the aetiology
of SITY is similar or different to stroke in the
elderly. Currently, there is a lack of consensus
guidelines on maximising secondary prevention in young adults with stroke. A rigorous and
comprehensive approach should investigate
causal mechanisms underlying SITY for appropriate treatment, prognosis and secondary
stroke prevention.
The following cohort was obtained from
an academic urban tertiary care hospital that
serves Northern Philadelphia, one of the
poorest regions in the USA. Eighty-five per
cent of patients are covered by government
programmes, including 31% by Medicare and
53% by Medicaid. In this cohort, young individuals comprised 10.2% of all patients with ischaemic stroke in a 4-year period. The proportion
of SITY from our study population is higher
than that reported in other cohorts, such as 2%
in L’Aquila, Italy,2 5% in a meta-analysis3 or 8%
in Northern Manhattan.4 This may be explained
be a high prevalence of vascular risk factors in
Northern Philadelphia, including widespread
hypertension and diabetes,5 increased rates of
drug and alcohol abuse,6 and a predominantly
African-American population.
This retrospective study aimed to characterise the various phenotypes of ischaemic
stroke in an economically disadvantaged population, using the ASCOD classification system.
Furthermore, the association between known
risk factors (ie, age, hypertension, diabetes, etc)
and specific ASCOD categories (atherosclerosis, small vessel disease, etc) was investigated.
Our purpose was a descriptive analysis of the
stroke aetiologies and risk factors most prevalent in a young urban population.
Methods
Selection and description of participants
A total of 1924 cases of ischaemic stroke were
retrospectively identified from an urban
tertiary care centre by searching Get With
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Stroke evaluation
All patients were initially evaluated by a neurologist with
a complete medical history and physical examination.
Initial studies included brain CT and MRI, routine blood
biochemistry and vascular studies of intracranial and
extracranial arteries (magnetic resonance angiogram
(MRA), computed tomography angiography (CTA),
carotid duplex, transcranial Dopplers, angiography).
Patients received a 12-lead ECG with a routine transthoracic echocardiogram; selective patients underwent
transoesophageal echocardiogram. Cardioembolism was
screened using ASCOD definitions of cardiac pathology,
including ejection fraction <35%, atrial fibrillation >60 s,
left atrial thrombus, endocarditis and so on. At the
neurologist’s discretion, patients also received a hypercoagulability work-up (antithrombin III, factor V Leiden
and prothrombin mutations, protein C and S deficiencies, antiphospholipid antibodies). If a high clinical suspicion for cardiac source of embolism was present without
evidence of structural heart disease, a loop recorder was
placed.
The hospital electronic database was used to collect
patient data, which included pertinent medical history,
hospitalisations, laboratory studies and imaging studies.
A vascular neurologist, senior neurology resident and
medical student then scored each stroke using the
ASCOD phenotyping. The team adjudicated ASCOD
scoring as a consensus.
ASCOD classification description
Previous methods of describing stroke aetiology focused
on a single casual risk factor. The ASCOD phenotyping
method describes all concurrent risk factors with varying
degrees of causation. The ASCOD classification system
represents five primary stroke aetiologies: atherosclerosis, small vessel disease (SVD), cardioembolism, other
and dissection.7 Within each aetiology, a numerical score
represents the degree of causality attributed to the stroke.
The scores are defined as 1, likely causal; 2, uncertain if
causal; and 3, unlikely causal, but disease present. The

score is determined by a combination of vascular imaging,
brain imaging, cardiac studies, laboratory results and
medical history. For instance, for atherosclerosis, A1 is
carotid stenosis >50%, A2 is carotid stenosis between 30%
and 50%, and A3 is the presence of atherosclerosis in any
vascular territory. For more details on the specific criteria,
please refer to the original paper ‘The ASCOD phenotyping of ischaemic stroke’ by Amarenco et al.
A score of 0 indicates no disease, and a score of 9 indicates incomplete work-up. Each stroke receives a score in
all five categories, for example, A1-S2-C0-03-D9 (atherosclerosis (likely causal), SVD (possibly causal), cardioembolism (absent), other (absent), dissection (incomplete
work-up)). Thus, ASCOD allows a detailed understanding
of the unique stroke to each individual patient.
In this study, a novel approach was taken to ASCOD
phenotyping. Typically, scorers adopt the higher grade,
that is, A1+A3 would be considered A1. However, all
grades present were included in this study. For example,
a patient with severe atherosclerosis both ipsilateral (A1)
and contralateral (A3) to the infarct, in addition to an
aortic plaque (A2), would be considered A1+A2+A3, not
only A1. The authors believed this would be a more inclusive method to capture all abnormalities present, rather
than just the more severe pathology.
Statistical analysis
Data were expressed as frequencies and percentages for
categorical variables and mean±SD (or range or quartile
range) for continuous variables. Multivariable multinomial logistic regression analyses were performed on the
ASCOD classifications to explore its association with other
potential predictors or confounding variables. All the
variables were entered into the model a priori without any
specific selection, first by introducing age, sex, hypertension, smoking and diabetes, and second by adding blood
lipids. However, none of the blood lipid variables showed
significant predictive abilities for the ASCOD groups and
hence were subsequently dropped. The adjusted ORs
with their 95% CIs are reported in table 3. P values less
than 0.05 were considered statistically significant. SAS
V.9.3 (SAS Institute, Cary, North Carolina, USA) was used
for all the data analyses.
Results
The study sample included 175 ischaemic strokes in
157 patients. Sixteen subjects (10.2%) experienced one
reinfarction, and 2 of those 16 had two reinfarctions.
Patients ranged from 20 to 50 years old, with 58.6% men
and 41.4% women. The cohort’s underlying risk factors
are detailed in table 1: 65.0% had hypertension, 40.8%
had diabetes, 33% had hyperlipidaemia and 61.8% were
smokers.
ASCOD distribution
Possibly causal phenotypes were defined as receiving grade
1 or 2 (table 2). Of possibly causal phenotypes, a cardiovascular aetiology was most prevalent (C1+C2=25.7%),

Liu A, et al. Stroke and Vascular Neurology 2018;3:e000139. doi:10.1136/svn-2017-000139

210

Stroke Vasc Neurol: first published as 10.1136/svn-2017-000139 on 30 July 2018. Downloaded from http://svn.bmj.com/ on 22 January 2019 by guest. Protected by copyright.

the Guidelines database from January 2011 to December
2014. The following criteria were applied: (1) age ≥18 and
≤50 at stroke onset; (2) discharge diagnosis of ischaemic
stroke. Ischaemic stroke was defined as acute focal neurological deficits lasting >24 hours with brain imaging corresponding to symptomatology.
A total of 175 ischaemic strokes met the inclusion
criteria. Patients with repeat infarcts were counted more
than once into the study. A repeat infarct was defined as
a new vessel occlusion in a different vascular territory or
new diffusion restriction. Enlarging infarcts or recrudescence of previous strokes were not considered a repeat
infarct.
MRI-negative strokes were defined as a persistent
deficit without radiological evidence of infarction and
were also included. Transient ischaemic attacks (TIAs)
were excluded.

Open access

N

Mean

Median

SD

Q1

Q3

Minimum

Maximum

Continuous variables
 Age

157

43.44

46.00

6.29

41.00

48.00

20.00

50.00

 NIHSS

151

5.51

4.00

5.35

2.00

7.00

0.00

26.00

 Homocysteine

150

10.68

9.75

4.64

7.90

12.00

3.30

38.20

 HbA1c

152

7.28

6.00

2.64

5.40

8.50

4.30

14.70

 T.Chol

155

182.57

172.00

57.09

150.00

202.00

92.00

415.00

 HDL

155

39.59

38.00

11.66

31.00

46.00

12.00

84.00

 TG

155

150.34

120.00

112.27

84.00

176.00

18.00

804.00

 LDL

151

110.98

107.00

41.55

86.00

129.00

35.00

303.00

Binary variables
 Gender, male

58.6% (92)

 Gender, female

41.4% (65)

 HTN

65% (102)

 Diabetes

40.8% (64)

 HLD
 Smoking

33.1% (52)
61.8% (97)

Binary variables expressed as % of total population (N).
HbA1C, glycated haemoglobin; HDL, high-density lipoprotein; HLD, hyperlipidaemia; HTN, hypertension; LDL, low-density lipoprotein;
N, number of subjects; NIHSS, National Institutes of Health Stroke Scale; Q1, first quartile; Q3, third quartile; T.Chol, total cholesterol; TG,
triglyceride.

followed by SVD (S1+S2=22.3%), and closely by atherosclerosis (A1+A2=21.1%). Only 6.3% of strokes had a
possible cause in the ‘other’ category. The least prevalent
possibly causal phenotype was dissection at 1.7%.
Aside from grades 1 and 2, almost half of the population scored A3 (46.3%), and almost a third scored O3
(30.9%). One-fourth of strokes received S3; similarly,
approximately one-fourth of strokes received C3. ‘Unclear
aetiology’ was defined as a stroke lacking a grade of 1 or
2, suggesting an undetermined causal mechanism. In this
cohort, 31.6% of all strokes were of unclear aetiology.
General phenotypes were defined as receiving grade 1
or 2 or 3. Of general phenotypes, atherosclerosis was the
most prevalent (51.4%), followed by SVD (47.4%), cardioembolism (42.3%) and other (35.4%). Dissection was
the (2.3%) least common general phenotype.
Table 3 shows the possibly causal phenotypes that overlapped, defined as receiving grade 1 or 2 in two separate
aetiologies. Moreover, 5.71% of strokes had both A and C

and 3.43% of strokes had both S and C. ‘Other’ had no
overlap with any other aetiology, and atherosclerosis and
SVD had no overlap.
ASCOD phenotype association with risk factors
Table 4 demonstrates whether specific risk factors were
predictive of grade 1 ASCOD phenotypes. Two significant
associations were discovered: subjects 45 and older were
more likely to develop a C1 or S1 stroke when compared
with subjects younger than 45. Gender, hypertension,
diabetes or smoking did not predict the odds of an A1,
S1, C1 or O1 stroke in this cohort. Additionally, no significant associations were found between risk factors and
possibly causal ASCOD phenotypes (grades 1+2).
Specific ASCOD grade breakdown
Table 5 details the specific pathologies within each
ASCOD grade. Of individuals receiving C1, there was one
individual with endocarditis, two cases of atrial fibrillation,

Table 2 Distribution of ischaemic strokes by ASCOD phenotype
1

2

3

0

9

1+2

1+2+3

Atherosclerosis 16.0% (28)
SVD
11.4% (20)

5.7% (10)
10.9% (19)

46.3% (81)
25.1% (44)

48.6% (85)
52.6% (92)

13.7% (24)
0.0%

21.1% (37)
22.3% (39)

51.4% (91)
47.4% (83)

Cardiac

12.0% (21)

14.3% (25)

22.3% (39)

54.8% (96)

2.9% (5)

25.7% (45)

42.3% (74)

5.7% (10)
1.7% (3)

0.6% (1)
0.0%

30.9% (54)
0.6% (1)

45.7% (80)
97.1% (170)

22.3% (39)
0.6% (1)

6.3% (11)
1.7% (3)

35.4% (62)
2.3% (4)

Other
Dissection

Data expressed as % of total population (N).
SVD, small vessel disease.
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Phenotype combination

% of total strokes, (n)

A1+A3
A1/A2+S1/S2

12.57 (22)
0.57 (1)

A1/A2+C1/C2

5.71 (10)

A1/A2+O1/O2

0 (0)

S1/S2+C1/C2

3.43 (6)

S1/S2+O1/O2

0 (0)

C1/C2+O1/O2
Unclear aetiology

0 (0)
31.60

Overlap between stroke phenotypes is demonstrated as % of all
strokes.

one heart transplant and the remaining individuals had
an ejection fraction <35%. Of individuals who received
a C2, the vast majority were C2(6), defined as ‘no direct
cardiac source identified, but multiple brain infarction,
repeated either bilateral or in two different arterial territories (…) and/or evidence of systemic emboli’.7
Of individuals receiving O1, three individuals had
moyamoya, two individuals had systemic lupus and one
individual had metastatic thyroid cancer compressing the
vertebral artery. Of individuals who received an O3, 10
had an elevated antiphospholipid antibody and 15 had
elevated homocysteine. Moreover, 12.6% of all strokes
had additional laboratories to suggest abnormal hypercoagulability, as specified in the Methods section.
Discussion
This study took a novel approach to ASCOD phenotyping
in a young, urban population by including all grades of
causality within each aetiology, and within each grade,
examining the stroke aetiologies in detail. The results
yielded several patterns, depending on how ASCOD
grades were combined. For possibly causal phenotypes,

the most prevalent categories were cardioembolism, SVD
and atherosclerosis, respectively. In contrast, for general
phenotypes, the order of prevalence shifted to atherosclerosis as the most common category, followed by SVD and
cardioembolism.
Atherosclerosis as the most prevalent general phenotype may be attributed to the high percentage of A3
(46.3%). Even in this young cohort, almost half of strokes
showed at least a minimal level of atherosclerosis. Sirimarco et al demonstrated that A3 conferred a similar risk
profile as A1 in a 3-year follow-up study for reinfarction,
non-fatal cardiac events and death from a vascular cause.8
Those results illustrate the need for aggressive control
of atherosclerosis, even at an early stage without clinical
symptoms. Furthermore, in this cohort, nearly 80% of A1
strokes had a concomitant A3 grade (12.6% of all strokes),
suggesting that atherosclerosis is present at additional
sites beyond the vessel supplying the infarct. Because this
subset of patients with ischaemic stroke had systemic,
rather than local, atherosclerosis, it was surprising to find
a low overlap of atherosclerosis (A1/A2) with cardiac
pathology (C1/C2). This result challenges the notion
that intracranial and extracranial atherosclerosis share
a similar pathophysiology to that of cardiac atherosclerosis. Interestingly, while research supports using carotid
intima–media thickness as a marker for future cardiac
events,9 this association is not always as strong in black
individuals, suggesting this surrogate marker may be
racially dependent.10 11
Cardioembolism as the most prevalent possibly causal
phenotype may be explained by 10.3% of all strokes
receiving a C2(6). In the ASCOD criteria, C2(6) is
defined as multiple brain infarcts in two vascular territories suggesting embolisms, with no identified cardiac
pathology. This definition is comparable with embolic
stroke of unknown source (ESUS).12 Key to the ESUS
definition is an embolic origin that is not necessarily
cardiac and also includes carotid/vertebral plaques,

Table 4 Multivariate adjusted associations of risk factors with phenotypes scoring a ‘1’ grade
Atherosclerosis (A1)

SVD (S1)

Cardioembolic (C1)

Other (O1)

Female

2.50 (0.95 to 6.62)
p=0.065

0.85 (0.26 to 2.76)
p=0.785

1.12 (0.40 to 3.11)
p=0.834

1.78 (0.43 to 7.38)
p=0.427

Age 45–50 vs <45

1.58 (0.59 to 4.26)

4.15 (1.0716.13)

3.44 (1.12 to 10.62)

0.248 (0.051.30)

p=0.363

p=0.040*

p=0.032*

p=0.099

Hypertension

0.94 (0.32 to 2.79)

1.48 (0.39 to 5.70)

1.44 (0.45 to 4.66)

3.80 (0.6821.41)

p=0.910

p=0.568

p=0.539

p=0.130

Diabetes

1.06 (0.37 to 3.05)

1.16 (0.35 to 3.78)

0.89 (0.30 to 2.61)

0.46 (0.10 to 2.11)

p=0.913

p=0.809

p=0.828

p=0.318

1.58 (0.55 to 4.54)
p=0.399

0.86 (0.28 to 2.68)
p=0.795

0.57 (0.21 to 1.54)
p=0.269

1.07 (0.26 to 4.44)
p=0.930

Smoking

Values are expressed as OR (95% CI) with p value below.
Strokes not receiving a one grade were used as a reference category.
*Indicates a significant p value.
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C1

Significant cardiac pathology and
single infarct
7.4% (13)

Left ventricle EF <35%

C2

Left ventricle apical akinesia and
decreased EF

No cardiac pathology but
multiple infarcts

4.0% (7)

10.3% (18)

Moyamoya disease

Systemic lupus

2.9% (5)

2.3% (4)

Abnormal hypercoagulability
laboratories (see Methods)
12.6% (22)

Homocysteinemia <40 μmol/L Antiphospholipid
AB <100 GPL units
8.6% (15)
5.7% (10)

O1
O3

2.3% (4)

Thrombocytosis <800 000/
mm3
2.9% (5)

Within each ASCOD grade, specific pathologies were quantified.
EF, ejection fraction.

aortic atheromas and rare variations of the circle of Willis.
Consequently, the true incidence of cardioembolism as
a causal mechanism may have been overestimated using
the ASCOD classification scheme in this cohort. Similarly
to the recommendations for cryptogenic stroke, additional high-quality trials should investigate whether the
C2(6) patient subgroup would benefit from systemic anticoagulation or antiplatelet therapy.13
The authors were interested by the substantial number
of O3 grades (30.9%), most of which were assigned due
to incidental laboratory findings, such as an elevated
homocysteine or positive antiphospholipid titre. Perhaps
these findings were inflammatory markers resulting
from the stroke or simply incidental laboratories. Wolf,
a creator of the ASCOD phenotyping system, stated the
aim of ASCOD was to best characterise the patient at
the moment of the ischaemic stroke and document all
abnormalities present.14 Whether these abnormalities are
causal, incidental or a result of the stroke is left to the
scorer’s discretion.
Multivariate logistic regression demonstrated that in
this study population, subjects 45 and older were more
likely to develop a cardioembolic or SVD stroke (C1 or
S1) than subjects younger than 45. This suggests that
the ‘young’ cohort may segregate into two extremes,
the very young and the older young. A similar statistical
model used by Jaffre et al found several more associations,
including cardioembolism with age and also atherosclerosis with age, smoking, diabetes, hypertension and
SVD with age and hypertension.15 Reasons why this study
cohort failed to replicate Jaffre et al’s findings include a
high baseline prevalence of hypertension, diabetes and
smoking, masking the risk factors’ impact. Furthermore,
this study’s variables were coded categorically rather than
continuously; using the numerical values may have yielded
a more sensitive detection of the various associations. In
this cohort, the absence of the risk factor’s predictive
value for stroke phenotype questions the use of stroke
classification systems. However, as Elkind writes in a recent
editorial, determining stroke aetiologies is valuable for
213

prognostication.16 In a study comparing various scoring
systems for stroke (ASCOD, TOAST, CCS), regardless
of the classification system, cardioembolic strokes were
associated with a decreased 90-day survival rate, a larger
infarct area and a more severe deficit, as compared with
other stroke aetiologies.17
Comparisons with other young cohorts reveal both
similarities and differences. The sifap1 study (Stroke in
Young Fabry Patients) found SVD (29.2%) and other
(16.5%) as the most prevalent possibly causal mechanisms, although this study included TIAs and had a
higher age cut-off of 55.18 In contrast, the Helsinki Young
Stroke Registry revealed cardioembolism (19.6%) and
dissection (15.4%) as the most common stroke mechanisms.19 The lower incidence of atherosclerosis in the
Helsinki cohort can be explained by a healthier baseline
population with lower incidence of obesity, hypertension,
diabetes and smoking. A more analogous population to
this study is the Northern Manhattan Study (NOMAS),
with multiple vascular risk factors and a high incidence
of African Americans and Hispanics. The findings of this
study were in line with NOMAS, which also had high
levels of undetermined aetiology and a low incidence of
cardioembolic strokes.4
This study had several limitations, including the high
percentage of incomplete work-up, which was attributed
to the rigorous application of ASCOD criteria for the 9
grade. Furthermore, this cohort had risk factors unique to
a low socioeconomic area, so the results may not be generalisable to other regions. Other characteristics impacting
stroke risk that merit further investigation include drug
and alcohol abuse, nutrition and environmental stressors.
Additionally, this statistical analysis included repeat
strokes (up to three strokes in one patient), which may
have over-represented aetiologies in recurrent strokes
such as untreated atrial fibrillation or moyamoya disease.
In summary, this study used the ASCOD phenotyping
system to describe aetiologies and their level of causality
to ischaemic stroke in individuals <50 years old. In this
urban cohort, the findings emphasise cardioembolism
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as the leading possibly causal mechanism and atherosclerosis as the leading general phenotype. As we have
attempted to demonstrate, the significance and implications of a stroke classification system are not limited
to its original definition. Ultimately, ASCOD scoring is
a dynamic process and can be applied to an individual
stroke to personalise secondary prevention and analysed
on a population level to detect patterns of risk factors.

